Janssen Stefan, Kaesmann Lukas, Schild Steven E, Rades Dirk
Department of Radiation Oncology, University of Lübeck, Lübeck, Germany Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany.
Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.
Anticancer Res. 2016 Apr;36(4):1825-8.
To compare three total radiation dose levels for their impact on survival in patients receiving palliative radiotherapy (RT) for locally advanced lung cancer.
Radiation dose (equivalent dose in 2 Gy fractions=EQD2: 31-40 Gy vs. 41-46 Gy vs. 47-52 Gy), completion of RT as planned, plus nine factors were analyzed for survival in 125 patients.
On multivariate analysis, EQD2 47-52 Gy (p=0.018), completion of planned RT (p=0.002), lower T-category (p=0.027) and lower N-category (p=0.008) were positively associated with survival. Thirty-six patients (29%) could not receive the complete planned RT dose, 19% in the 31-40 Gy group, 36% in the 41-46 Gy group and 31% in the 47-52 Gy group, respectively. Six-month survival rates of these patients were 0%, 18% and 18%, respectively.
Higher RT doses resulted in significantly better survival than lower doses. The favorable results were impaired when the planned treatment could not be completed.
比较三种总辐射剂量水平对局部晚期肺癌接受姑息性放疗(RT)患者生存的影响。
分析了辐射剂量(2 Gy 分次等效剂量=EQD2:31 - 40 Gy 对比 41 - 46 Gy 对比 47 - 52 Gy)、按计划完成放疗情况,以及125例患者生存情况的九个因素。
多因素分析显示,EQD2 为 47 - 52 Gy(p = 0.018)、按计划完成放疗(p = 0.002)、较低的 T 分期(p = 0.027)和较低的 N 分期(p = 0.008)与生存呈正相关。36例患者(29%)未能接受完整的计划放疗剂量,31 - 40 Gy组为19%,41 - 46 Gy组为36%,47 - 52 Gy组为31%。这些患者的六个月生存率分别为0%、18%和18%。
较高的放疗剂量比较低剂量能显著提高生存率。当无法完成计划治疗时,良好的结果会受到影响。